Optimal Genome Mapping Offers High-Res Method to Help Diagnose Cancer-Causing Gene Variants
Optical genome mapping can outperform standard tests used for common blood cancers and help make better, more specific, diagnosis.
Read MorePosted by Andy Lundin | Jan 17, 2023 | Molecular Diagnostics |
Optical genome mapping can outperform standard tests used for common blood cancers and help make better, more specific, diagnosis.
Read MorePosted by Andy Lundin | Jan 13, 2023 | Covid 19, Rapid Assays |
eMed partnered with NIH and ASPR to provide at-home treatment based on telehealth evaluations and rapid COVID test results.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Covid 19 |
Fusion Genomics has established a fully automated, infectious-disease surveillance facility at Toronto Pearson International Airport.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Company News, Diagnostic Technologies |
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read More